west virginia glp-1 side effect lawsuit patients are left in limbo over changing insurance coverage of obesity medications ATLANTA - A Georgia woman

Based on clinical trial data from Novo Nordisk, people who took the pill along with maintaining a reduced-calorie diet and increased physical activity lost an average of 13% of their body weight over 64 weeks

The preclinical results were confirmed and expanded in human studies: GLP-1RAs reduced alcohol consumption in patients with alcohol-related disorders who are of normal weight or have comorbid diseases such as obesity or type 2 diabetes

Ozempic works as a GLP-1 (glucagon-like peptide-1) receptor agonist, which means it mimics the action of a hormone naturally produced in the body

So were trying to figure out how employers can get something along those lines. CEO, health benefits organization We were talking to a Canadian advisor